Knowledge Distillery

Hitherto no therapeutic has received regulatory approval for the treatment of Post-COVID-19 Condition (PCC). Cognitive deficits, mood symptoms, and…

A variety of neurologic disorders have been reported as presentations or complications of coronavirus disease 2019 (COVID-19) infection.

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), rapidly spread across the globe.

Coronavirus disease 2019 (COVID-19) has been associated with nervous system involvement, with more than one-third of COVID-19 patients experiencing…

Data regarding the risk of ischemic stroke within 1 year after the post-acute phase of COVID-19 remain scant. In this systematic review and…

In the fourth year of the COVID-19 pandemic, mortality rates decreased, but the risk of neuropsychiatric disorders remained the same, with a…

In this prospective study the authors aimed to characterize neurologic manifestations in post-hospitalization Neuro-PASC (PNP) and non-hospitalized…

Post-COVID condition (PCC) is common and often involves neuropsychiatric symptoms. This study aimed to use blood-oxygenation-level-dependent…

The objective of this study was to investigate the prognostic value of blood neurofilament light chain protein (NfL) levels in the acute phase of…

The COVID-19 pandemic has been associated amongst others with a sharp increase in adolescents and young adults presenting acutely with functional…

Peroxisome injury occurs in the central nervous system (CNS) during multiple virus infections that result in neurological disabilities. In this…

COVID-19 affects the brain, leading to long-term complaints. Studies combining brain abnormalities with objective and subjective consequences are…